Tags : supports BeiGene


NMPA, China Accepts NDA for BeiGene & Boehringer BioChina’s Tislelizumab

Shots:  Boehringer Ingelheim (BI) and BeiGene are in collaboration since 2013 for the development of tislelizumab BI BioXcellence is providing CMC services and also helping BeiGene with process & analytical method, supply of GMP clinical material, and CMC filing support with the NMPA Boehringer claims to provide manufacturing support to BeiGene for tislelizumab for global […]Read More